Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation - Concepedia

Concepedia

Publication | Closed Access

Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation

23

Citations

32

References

2020

Year

Brennan J. Wadsworth, Rachel A. Cederberg, Che-Min Lee, Natalie Firmino, S. Elizabeth Franks, Jinhe Pan, Nadine Colpo, Kuo‐Shyan Lin, François Bénard, Kevin L. Bennewith

Tumor BiologyRadiation MedicineOncologyTumour ResponseRadiation TherapyTransient HypoxiaReceptor Blocker TelmisartanMedicineRadiopharmaceutical TherapyVascular BiologyPharmacotherapyPharmacologyRadiation OncologyTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1

Page 1